| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Manufacturing Officer | SVP, Operations
1 company
James Leal last filed a Form 4 in May 2024, as Chief Manufacturing Officer at TNDM. James Leal's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, James Leal's trades have earned a strong insider score of 74/100 across 8 rated trades. Over a 12-month horizon, all 8 of those trades were profitable, with an average 12-month return of +57.5%.
At the last filing, the largest reported position was 16,876 shares of TNDM. The TNDM filings lean toward selling, a net 21,662 shares.
James Leal has 29 Form 4 filings on record from June 2021 to May 2024, all as Chief Manufacturing Officer at Tandem Diabetes Care (TNDM), 2021–2024.
The 93 reported transactions were 41 option exercises, 28 tax withholdings, 15 open-market sales and 5 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 8 sales worth about $2.5M.
The largest open-market sale was 7,135 shares of TNDM at an average $100.00 on June 28, 2021, about $714K. Twelve months later TNDM was down 39%.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 27, 2021 | TNDM Tandem Diabetes Care Inc | SVP, Operations | Sale+OE | 1,906 | $151.45 | $288,665.60 | -32.2% | -25.9% | -72.4% | |
| Nov 29, 2021 | TNDM Tandem Diabetes Care Inc | SVP, Operations | Sale+OE | 1,905 | $130.96 | $249,478.20 | -32.2% | -13.8% | -69.4% | |
| Oct 27, 2021 | TNDM Tandem Diabetes Care Inc | SVP, Operations | Sale+OE | 1,904 | $130.34 | $248,167.36 | -33.7% | -10.0% | -58.5% | |
| Sep 27, 2021 | TNDM Tandem Diabetes Care Inc | SVP, Operations | Sale+OE | 1,905 | $121.72 | $231,882.03 | -33.7% | +26.1% | -61.6% | |
| Sep 7, 2021 | TNDM Tandem Diabetes Care Inc | SVP, Operations | Sale+OE | 3,574 | $123.00 | $439,602.00 | -48.8% | +1.2% | -64.7% | |
| Aug 27, 2021 | TNDM Tandem Diabetes Care Inc | SVP, Operations | Sale+OE | 1,667 | $110.64 | $184,442.04 | -30.8% | +17.5% | -57.7% | |
| Jul 27, 2021 | TNDM Tandem Diabetes Care Inc | SVP, Operations | Sale+OE | 1,666 | $102.25 | $170,349.17 | -31.7% | +26.7% | -36.5% | |
| Jun 28, 2021 | TNDM Tandem Diabetes Care Inc | SVP, Operations | Sale+OE | 7,135 | $100.00 | $713,500.00 | -66.5% | +21.8% | -39.4% |